2011
DOI: 10.1016/j.radonc.2011.09.012
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
80
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 105 publications
(86 citation statements)
references
References 45 publications
6
80
0
Order By: Relevance
“…Toxicities were dependent on tumor location: treatment of central tumors was associated with grade 4 (n=2) and grade 5 (n=3) toxicities. Peripheral tumors, however, had no grade 4-5 toxicities (6). These findings support the use of cautious salvage SBRT in carefully selected patients.…”
supporting
confidence: 67%
“…Toxicities were dependent on tumor location: treatment of central tumors was associated with grade 4 (n=2) and grade 5 (n=3) toxicities. Peripheral tumors, however, had no grade 4-5 toxicities (6). These findings support the use of cautious salvage SBRT in carefully selected patients.…”
supporting
confidence: 67%
“…Serious side-effects with massive lung bleeding after re-irradiation of central lung tumors was described, mainly in large target volumes and central tumor locations, by Peulen, et al [4]. In our case, temporary hemoptysis occurred in April 2011 which was most probably induced by local tumor recurrence (malignant cells found after cytologic evaluation) and not regarded as late radiation toxicity.…”
Section: Discussionsupporting
confidence: 47%
“…Recently, also repeated radiation treatments are considered if there is not too much of dose overlap and/or a small clinical target volume involved. Repeated radiation treatments in the same lung localization are not yet well-defined and biological tissue effects, such as late toxicity, are described [3][4]. We here present a rare case of a lung cancer patient who was treated over twenty-six years with surgery and multiple radiation treatments, mainly in the region of the right middle lobe.…”
Section: Introductionmentioning
confidence: 96%
“…CyberKnife). SRT appears to be an acceptable treatment option for recurrent tumors, and several series report high rates of local control and low incidence of complication in SRT for re-RT of NSCLC [14][15][16][17][18]. We hypothesized that SRT (both FSRT and SBRT) was a safe and efficacious treatment modality for R/SP-MLNMs from NSCLC.…”
Section: Introductionmentioning
confidence: 99%